• Home
  • Events
  • News
  • Contact us
  • Log in
DFG and the Israel Science Foundation Agree to Intensify Collaboration

DFG and the Israel Science Foundation Agree to Intensify Collaboration

by ATHENA | Nov 15, 2023 | News

The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) and its Israeli partner organisation, the Israel Science Foundation (ISF), have agreed to pursue their cooperation in greater depth. The two funding organisations now concluded a memorandum of...
2023 European Innovative Teaching Award event, 24/11/2023

2023 European Innovative Teaching Award event, 24/11/2023

by ATHENA | Nov 15, 2023 | Workshops

The European Innovative Teaching Award is a European Commission initiative launched in 2021, which aims to highlight and reward the work of teachers and schools, and to showcase innovative teaching practices. The initiative forms part of the broader European...
Workshop: connecting higher education, teacher training and schools to advance education for the digital and green transitions, 22/11/2023

Workshop: connecting higher education, teacher training and schools to advance education for the digital and green transitions, 22/11/2023

by ATHENA | Nov 15, 2023 | Workshops

The objective of the workshop to identify key lessons on how public policy can support more structured connections between higher education, teacher training institutes and schools. International policy makers and practitioners will discuss how to strengthen the...
Newsletter :  Widening participation and spreading excellence

Newsletter : Widening participation and spreading excellence

by ATHENA | Nov 15, 2023 | News

ec.europa.eu/newsroom/rea/newsletter-archives/48861
VectorY Raises €129 Million ($138 Million) Series A Financing to Advance Vectorized Antibody Programs in Neurodegenerative Diseases

VectorY Raises €129 Million ($138 Million) Series A Financing to Advance Vectorized Antibody Programs in Neurodegenerative Diseases

by ATHENA | Nov 14, 2023 | News

VectorY Therapeutics, a biotech company developing innovative vectorized antibody therapies for the treatment of neurodegenerative diseases, today announced the close of a €129 million ($138 million) Series A financing to advance its vectorized antibody programs in...
« Older Entries
Next Entries »

Recent Posts

  • Autumn break
  • Bio-based Europe Alliance
  • 6 cities competing for the 2027 European Capital of Innovation Awards (iCapital)
  • European Parliament set out its position on EU’s 2027 budget
  • UKRI backs quantum breakthroughs supported by training

Recent Comments

No comments to show.
News | Contact | Team |
  • Follow
  • Follow
  • Follow
  • Follow

Copyright © 2024 ATHENA. All Rights Reserved.